- Home
- CWD vs BMRA Comparison
CWD vs BMRA Comparison
Compare CWD & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWD
- BMRA
- Stock Information
- Founded
- CWD 2009
- BMRA 1971
- Country
- CWD United States
- BMRA United States
- Employees
- CWD N/A
- BMRA N/A
- Industry
- CWD Real Estate
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CWD Finance
- BMRA Health Care
- Exchange
- CWD Nasdaq
- BMRA Nasdaq
- Market Cap
- CWD 12.1M
- BMRA 11.2M
- IPO Year
- CWD 2023
- BMRA N/A
- Fundamental
- Price
- CWD $0.50
- BMRA $0.57
- Analyst Decision
- CWD
- BMRA
- Analyst Count
- CWD 0
- BMRA 0
- Target Price
- CWD N/A
- BMRA N/A
- AVG Volume (30 Days)
- CWD 244.5K
- BMRA 187.3K
- Earning Date
- CWD 03-31-2025
- BMRA 04-11-2025
- Dividend Yield
- CWD N/A
- BMRA N/A
- EPS Growth
- CWD N/A
- BMRA N/A
- EPS
- CWD N/A
- BMRA N/A
- Revenue
- CWD $51,119,000.00
- BMRA $5,578,000.00
- Revenue This Year
- CWD N/A
- BMRA N/A
- Revenue Next Year
- CWD $33.62
- BMRA N/A
- P/E Ratio
- CWD N/A
- BMRA N/A
- Revenue Growth
- CWD N/A
- BMRA 1.40
- 52 Week Low
- CWD $0.37
- BMRA $0.24
- 52 Week High
- CWD $1.05
- BMRA $1.27
- Technical
- Relative Strength Index (RSI)
- CWD 38.38
- BMRA 41.40
- Support Level
- CWD $0.48
- BMRA $0.55
- Resistance Level
- CWD $0.68
- BMRA $0.74
- Average True Range (ATR)
- CWD 0.09
- BMRA 0.05
- MACD
- CWD -0.01
- BMRA -0.01
- Stochastic Oscillator
- CWD 8.46
- BMRA 12.05
About CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm, whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. Majority of revenue is derived from Asset management fees segment.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.